SIFI Pharma - Product Pipeline Review - 2012

Global Markets Direct, July 2012, Pages: 29

SIFI Pharma – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “SIFI Pharma - Product Pipeline Review - 2012” provides data on the SIFI Pharma’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, SIFI Pharma’s corporate website, SEC filings, investor presentations and featured press releases, both from SIFI Pharma and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- SIFI Pharma - Brief SIFI Pharma overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of SIFI Pharma human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of SIFI Pharma with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the SIFI Pharma’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate SIFI Pharma’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of SIFI Pharma in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the SIFI Pharma’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with SIFI Pharma.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of SIFI Pharma and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of SIFI Pharma; SIFI Pharma - Key Therapeutics; SIFI Pharma - Pipeline Overview and Promising Molecules; SIFI Pharma - News; SIFI Pharma - Latest Updates; SIFI Pharma - Pipeline; SIFI Pharma - Discontinued/Dormant Projects

2
List of Tables 4
List of Figures 4
SIFI Pharma Snapshot 5
SIFI Pharma Overview 5
Key Information 5
Key Facts 5
SIFI Pharma – Research and Development Overview 6
Key Therapeutic Areas 6
SIFI Pharma – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
SIFI Pharma – Pipeline Products Glance 10
SIFI Pharma – Late Stage Pipeline 10
Registration Filed Products/Combination Treatment Modalities 10
SIFI Pharma – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
SIFI Pharma – Drug Profiles 13
SF 101 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
SF 102 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
SF 103 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
SF 104 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
SF 105 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
SF 106 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
SF 107 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SF 108 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
SF 109 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
SF 110 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
SF 111 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SF 113 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
SF 116 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
SIFI Pharma – Pipeline Analysis 26
SIFI Pharma – Pipeline Products by Therapeutic Class 26
SIFI Pharma – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29

List of Tables
SIFI Pharma, Key Information 5
SIFI Pharma, Key Facts 5
SIFI Pharma – Pipeline by Indication, 2012 7
SIFI Pharma – Pipeline by Stage of Development, 2012 8
SIFI Pharma – Monotherapy Products in Pipeline, 2012 9
SIFI Pharma – Filed, 2012 10
SIFI Pharma – Pre-Clinical, 2012 11
SIFI Pharma – Discovery, 2012 12
SIFI Pharma – Pipeline By Therapeutic Class, 2012 26
SIFI Pharma, Other Locations 27

List of Figures
SIFI Pharma – Pipeline by Indication, 2012 7
SIFI Pharma – Pipeline by Stage of Development, 2012 8
SIFI Pharma – Monotherapy Products in Pipeline, 2012 9
SIFI Pharma – Pipeline By Therapeutic Class, 2012 26

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• SunGard - Profile - US
• eBay - Strong Execution
• Scientific Games Corporation - Company Analysis
• Insight into Samsung Electronics' Notebook PC Business Model
• Amazon - Point of Realization in 2013?
• Accenture - Profile - US
• Dell - Profile - US